Key Takeaways
- Beyond Meat’s Q4 2025 earnings release is scheduled for Tuesday, March 31, after market hours, postponed from March 25 following disclosure of “material weaknesses” in financial reporting controls.
- Analyst consensus calls for approximately $63 million in quarterly revenue, representing an 18% decline year-over-year, alongside an anticipated per-share loss of $0.10.
- The options market indicates exceptional volatility expectations, with a 30% price movement in either direction post-report — significantly exceeding the company’s historical 7–10% earnings reaction range.
- The plant-based protein company faces a Nasdaq minimum bid price deficiency notice after trading under $1 for 30 consecutive trading days, with a compliance deadline of August 31, 2026, potentially forcing a reverse stock split.
- Major institutional investors substantially increased their stakes in Q4, including Geode Capital Management (up 445%), Charles Schwab (up 497%), and Virtu Financial (up 670%), bringing total institutional ownership to 52.48%.
The company that once captivated growth investors as a plant-based revolution pioneer now finds itself trading as a penny stock facing critical scrutiny ahead of a high-stakes quarterly report.
The alternative protein manufacturer is set to unveil its fourth quarter 2025 financial results following Tuesday’s closing bell on March 31. Initially slated for March 25, the earnings announcement was postponed after Beyond Meat disclosed significant deficiencies in its internal financial oversight mechanisms. This revelation independently triggered investor concern before any numbers were released.
Street consensus projects quarterly sales near $63 million, though the company has already preannounced softer preliminary results — internal guidance suggests Q4 revenue closer to $61 million. This shortfall relative to analyst projections indicates persistent demand challenges. Full-year revenue is forecast to decline approximately 10% to $275 million.
The anticipated per-share loss of roughly $0.10 would represent meaningful improvement from the $0.65 loss recorded in the comparable year-ago period. This narrowing deficit stands as one of few positive data points investors can identify ahead of Tuesday’s disclosure.
On March 16, the company announced it would delay its annual Form 10-K submission to conduct additional inventory assessments. Mizuho Securities analyst John Baumgartner, maintaining an Underperform rating with a $1 price objective, flagged this development as particularly concerning. He highlighted deteriorating demand fundamentals across core geographic markets and noted intensifying competitive pressures in the protein beverage category where Beyond Meat is attempting expansion.
The overall analyst community remains predominantly negative on the stock. BYND currently carries six Sell ratings and two Hold ratings, with no Buy recommendations. The average price target sits at $1.70 — notably above current trading levels. Weiss Ratings maintained its “sell (e+)” assessment in a January update.
Compliance Crisis and the Nasdaq Countdown
Beyond the quarterly financial results, the company confronts an existential regulatory challenge. Beyond Meat has been issued a Nasdaq Stock Market deficiency notice following 30 consecutive business days with a closing bid price below the required $1.00 minimum. The exchange has granted the company until August 31, 2026, to regain compliance by sustaining a closing bid at or above $1.00 for a minimum of ten consecutive trading days. Failure to meet this requirement would likely necessitate a reverse stock split to artificially boost the share price.
Shares have plummeted approximately 77% over the trailing twelve-month period. The stock’s 50-day simple moving average rests at $0.78, while its 200-day moving average sits at $1.28 — both technical indicators remain substantially above current price levels, signaling persistent downward momentum.
Derivatives Trading Points to Exceptional Volatility
Options market participants are anticipating an extraordinary 30% price swing in either direction following the earnings announcement. This implied volatility level represents three to four times Beyond Meat’s standard post-earnings movement range of 7–10%.
Applied to the current share price near $0.65, a 30% movement would establish a potential trading range between approximately $0.46 on the downside and $0.85 on the upside. The lower boundary would bring BYND perilously close to its all-time low of $0.50.
Paradoxically, certain sophisticated institutional investors have been aggressively accumulating shares despite the negative sentiment. Geode Capital Management expanded its holdings by 445% during the fourth quarter, Charles Schwab Investment Management increased its position by 497%, and Virtu Financial boosted its stake by 670%. Collectively, institutional investors now control approximately 52.48% of outstanding shares.
The analyst community continues to express limited optimism for near-term appreciation, citing ongoing revenue contraction, unresolved accounting control deficiencies, and the looming Nasdaq compliance deadline that began its countdown in early 2026.


